Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Drops After-Hours on Subpoena Disclosure
Barron's
Saturday, June 11, 2011 - 10:28am
tags:
Gilead Sciences, legal
Bayer Seeks European Approval
Yahoo/Zacks
Saturday, June 11, 2011 - 10:27am
tags:
Bayer, VEGF Trap-Eye, age-related macular degeneration
Great Data! Now Lets See More Than 12 Patients
Motley Fool
Saturday, June 11, 2011 - 10:25am
tags:
Micromet, leukemia, blinatumomab
Gilead gets subpoena from Justice Department
MarketWatch
Saturday, June 11, 2011 - 10:23am
tags:
Gilead Sciences, Atripla, Emtriva, Hepsera, Letairis, Truvada, Viread
Exelixis, YM Biosciences Lead Losers at Cancer Meeting
Minyanville
Saturday, June 11, 2011 - 10:22am
tags:
Exelixis, YM BioSciences
Drug stocks follow broader market south
MarketWatch
Saturday, June 11, 2011 - 10:21am
tags:
investors
PharmAthene Announces $6.5 Million Registered Direct Offering
Yahoo
Friday, June 10, 2011 - 10:36am
tags:
PharmAthene, stock offering
Chelsea Therapeutics soars on price target upgrade
Marketwatch
Friday, June 10, 2011 - 10:35am
tags:
Chelsea Therapeutics
Pfizer's Dividend Is Safe
Motley Fool
Friday, June 10, 2011 - 10:34am
tags:
Pfizer, dividends
Baxter Loses First Heparin Lawsuit
Pharmalot
Friday, June 10, 2011 - 9:28am
tags:
Baxter International, blood thinners, Heparin, lawsuits
Japan health ministry: no plans for Actos recall
Reuters
Friday, June 10, 2011 - 9:23am
tags:
Actos, Takeda, diabetes, Japan
Micromet Gains After Leukemia Medicine Helps Patients in Study
Bloomberg
Friday, June 10, 2011 - 9:21am
tags:
Micromet, leukemia, blinatumomab
Ziopharm gets FDA approval to conduct human trials of a potential melanoma treatment
Yahoo/AP
Friday, June 10, 2011 - 9:20am
tags:
FDA, melanoma, Ziopharm, ZIN ATI-001
France, Germany Halt Use of Takeda’s Actos
WSJ Online
Friday, June 10, 2011 - 9:19am
tags:
Takeda, Actos, Europe, France, Germany, diabetes
Allergan's survival strategy: Botox everlasting
CNN Money
Friday, June 10, 2011 - 9:16am
tags:
Allergan, Botox
UCB Pays $34 Million and Pleads Guilty in Epilepsy Drug Fraud Case
NY Times, NY
Thursday, June 9, 2011 - 10:49pm
tags:
UCB Pharmaceuticals, Keppra, epilepsy, off-label
Is Regeneron Pharmaceuticals the Perfect Stock?
Motley Fool
Thursday, June 9, 2011 - 10:47pm
tags:
Regeneron
PDL BioPharma cuts 2Q revenue outlook due to error
Yahoo/AP
Thursday, June 9, 2011 - 7:47pm
tags:
PDL Biopharma, earnings, guidance
It's a Numbers Game With Vertex
Motley Fool
Thursday, June 9, 2011 - 7:44pm
tags:
Vertex Pharmaceuticals, CF, cystic fibrosis, VX-770
Abbott releases early results of Parkinson's study
Yahoo/AP
Thursday, June 9, 2011 - 7:31pm
tags:
Abbott Laboratories, Parkinson's Disease

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.